Evaluating the Anti-tumor efficacy and safety of AEV01 in Glioma and Hepatocellular Carcinoma: An In Vitro and In Vivo approach.
I. Biswas, D. Precilla, A. Kumar, S. MM, R. Medasani, A. T. S
This study evaluates the anti-tumor efficacy and safety of AEV01 in glioma and hepatocellular carcinoma using in vitro and in vivo models, finding dose-dependent cytotoxicity and reduced tumor markers with no significant organ toxicity.
bioRxiv · Jul 22, 2024 · PreprintCancer Biology